Schrodinger (NASDAQ:SDGR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.44 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.13) by $0.57, Zacks reports. Schrodinger had a negative return on equity of 48.24% and a negative net margin of 68.49%.
Here are the key takeaways from Schrodinger’s conference call:
- The company is accelerating a shift from on‑prem to a hosted model (target ~75% hosted by 2028), which will cause near‑term revenue recognition headwinds and compress gross margins/adjusted EBITDA despite no change to ACV or cash; management says each 1% increase in hosted mix roughly reduces current‑year revenue by $2–$3M.
- Schrödinger guided full‑year 2026 software ACV of $218M–$228M (10%–15% growth) and reiterated a path to positive adjusted EBITDA by end of 2028, supported by a strong cash position (~$400M) to fund growth and the hosted transition.
- 2025 results showed solid momentum: total revenue of $256M (23% YoY growth), software ACV ~$198.5M, software revenue ~$199.5M, and an improved net loss of $103M vs $187M in 2024 with operating expenses down ~9%.
- Therapeutics remains a material optional upside — drug discovery revenue was $56.4M in 2025, the company has 16 programs eligible for royalties and up to ~$5B in possible future milestones, and near‑term clinical catalysts include phase I readouts (SGR‑1505/3515) and WEE1/Myt1 data expected in Q2.
- New products and AI positioning are expected to drive incremental growth: the Predictive Tox beta outperformed expectations, multiple product launches are included in the 3‑year growth plan, and management argues its physics‑plus‑AI platform benefits from rising agentic AI compute demand under a throughput licensing model.
Schrodinger Price Performance
Shares of Schrodinger stock traded up $0.50 on Wednesday, reaching $11.80. The stock had a trading volume of 1,489,051 shares, compared to its average volume of 1,639,757. Schrodinger has a fifty-two week low of $11.11 and a fifty-two week high of $27.63. The business’s 50-day moving average price is $15.68 and its two-hundred day moving average price is $17.96.
Institutional Trading of Schrodinger
Wall Street Analysts Forecast Growth
A number of research analysts recently commented on SDGR shares. TD Cowen reaffirmed a “buy” rating on shares of Schrodinger in a research report on Thursday, January 8th. KeyCorp lowered their price target on Schrodinger from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, January 8th. Bank of America raised shares of Schrodinger from a “neutral” rating to a “buy” rating and set a $24.00 price objective on the stock in a research report on Monday, December 15th. Wall Street Zen raised shares of Schrodinger from a “sell” rating to a “hold” rating in a research report on Saturday, January 31st. Finally, UBS Group initiated coverage on shares of Schrodinger in a research note on Wednesday, January 7th. They set a “neutral” rating and a $18.00 price target on the stock. Five analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Schrodinger has an average rating of “Hold” and a consensus target price of $24.33.
Check Out Our Latest Stock Report on SDGR
About Schrodinger
Schrödinger, Inc is a life sciences and materials discovery company that specializes in the application of physics-based computational platforms to accelerate drug discovery and advanced materials design. Founded in 1990 by Professor Richard A. Friesner, Schrödinger has developed a suite of proprietary software tools—such as Maestro for molecular modeling, Glide for molecular docking and Jaguar for quantum chemistry calculations—that enable scientists to predict molecular behavior with high accuracy.
Further Reading
- Five stocks we like better than Schrodinger
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.
